SCHEMBL606358

SCHEMBL606358

CCC=CCC=CCC=CC/C=C\CCCCC(=O)O

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.96
▸ PPARG P37231 8/20 0.96
▸ F7 P08709 7/20 0.96
▸ F3 P13726 7/20 0.96
▸ CYP19A1 P11511 6/20 0.96
▸ PPARD Q03181 6/20 0.96
▸ PPARA Q07869 6/20 0.96
▸ PTGS1 P23219 5/20 0.96
▸ FFAR1 O14842 5/20 0.96
▸ MAPT P10636 4/20 0.96
▸ OXER1 Q8TDS5 4/20 0.96
▸ KMT2A Q03164 3/20 0.96
▸ L3MBTL1 Q9Y468 3/20 0.96
▸ KDM4E B2RXH2 3/20 0.96
▸ LMNA P02545 3/20 0.96
▸ CYP3A4 P08684 3/20 0.96
▸ HPGD P15428 3/20 0.96
▸ ALOX15 P16050 3/20 0.96
▸ HSD17B10 Q99714 3/20 0.96
▸ TDP1 Q9NUW8 3/20 0.96

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7755128 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL14695123 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL15994739 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL606015 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL371515 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL4452323 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL29226 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL10444557 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL2574641 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1
SCHEMBL14161584 1.00 ALDH1A1 (0.96) ALDH1A1PPARGF7F3CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112996500-A Compositions and methods for modulating ELOVL2 优美佳生物技术有限公司 2021-06-18 — — CN claimed
EP-4568643-A1 COMPOSITIONS COMPRISING AMAROUCIAXANTHIN A ESTERS AND USES THEREOF Gat Therapeutics S.L. (ES) 2025-06-18 — — EP disclosed
US-20240225009-A1 METHOD FOR IMPROVING THE RAINFASTNESS OF BENEFICIAL MICROORGANISMS SPECIALITY OPERATIONS FRANCE (FR) 2024-07-11 — — US disclosed
EP-2405903-B1 COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF BASF AS (NO) 2024-04-10 — — EP disclosed
WO-2024013306-A1 COMPOSITIONS COMPRISING AMAROUCIAXANTHIN A ESTERS AND USES THEREOF GAT THERAPEUTICS, S.L. (ES) 2024-01-18 — — WO disclosed
EP-4306101-A1 COMPOSITIONS COMPRISING AMAROUCIAXANTHIN A ESTERS AND USES THEREOF Gat Therapeutics S.L. (ES) 2024-01-17 — — EP disclosed
US-20230218560-A1 COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF PRONOVA BIOPHARMA NORGE AS (NO) 2023-07-13 — — US disclosed
WO-2023094524-A1 AGRICULTURAL ACTIVE COMPOSITION COMPRISING A GLYOXAL-MODIFIED POLYSACCHARIDE RHODIA OPERATIONS (FR) 2023-06-01 — — WO disclosed
US-11612579-B2 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof PRONOVA BIOPHARMA NORGE AS (NO) 2023-03-28 — — US disclosed
US-11523999-B2 Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof PRONOVA BIOPHARMA NORGE AS (NO) 2022-12-13 — — US disclosed
EP-1307108-A2 OIL/FAT COMPOSITION Kao Corporation (JP) 2003-05-07 — — EP disclosed
WO-2002011550-A2 OIL/FAT COMPOSITION KAO CORPORATION (JP) 2002-02-14 — — WO disclosed
WO-2002011552-A2 OIL/FAT COMPOSITION KAO CORPORATION (JP) 2002-02-14 — — WO disclosed
WO-2002011551-A2 OIL/FAT COMPOSITION KAO CORPORATION (JP) 2002-02-14 — — WO disclosed
US-6303588-B1 APPLYING TO PORTIONS OF THE SKIN OF SUCH PATIENT WHICH HAVE ABNORMAL SKIN CELL METABOLISM BIOACTIVE AGENT COMPRISING ADENOSINE-5-TRIPHOSPHATE, QUANOSINE-5-TRIPHOSPHATE AND PHOSPHINOSITEDES AND BIOLOGICALLY ACCEPTABLE CARRIER Danielov, Michael M. 2001-10-16 — — US disclosed
WO-2001075069-A1 PROCESS FOR PRODUCING LIPIDS AND LIPID-SECRETING MICROORGANISMS IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2001-10-11 — — WO disclosed
US-6174712-B1 REACTING AN UNSATURATED FATTY ACID HAVING 16 TO 24 CARBON ATOMS AND A LIPOXYGENASE, THEN APPLYING PRODUCT TO PLANT SHISEIDO COMPANY, LTD. (JP) 2001-01-16 — — US disclosed
EP-0652749-A4 METHODS AND COMPOSITIONS FOR INHIBITING 5-g(a)-REDUCTASE ACTIVITY. ARCH DEV CORP (US) 1997-04-09 — — EP disclosed
EP-0652749-A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY ARCH DEVELOPMENT CORPORATION (US) 1995-05-17 — — EP disclosed
WO-1994001100-A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY ARCH DEVELOPMENT CORPORATION (US) 1994-01-20 — — WO disclosed
Send feedback